Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
Leber MF, Bossow S, Leonard VH, Zaoui K, Grossardt C, Frenzke M, Miest T, Sawall S, Cattaneo R, von Kalle C, Ungerechts G. Leber MF, et al. Among authors: ungerechts g. Mol Ther. 2011 Jun;19(6):1097-106. doi: 10.1038/mt.2011.55. Epub 2011 Apr 5. Mol Ther. 2011. PMID: 21468006 Free PMC article.
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus.
Baertsch MA, Leber MF, Bossow S, Singh M, Engeland CE, Albert J, Grossardt C, Jäger D, von Kalle C, Ungerechts G. Baertsch MA, et al. Among authors: ungerechts g. Cancer Gene Ther. 2014 Sep;21(9):373-80. doi: 10.1038/cgt.2014.40. Epub 2014 Aug 22. Cancer Gene Ther. 2014. PMID: 25145311
CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.
Engeland CE, Grossardt C, Veinalde R, Bossow S, Lutz D, Kaufmann JK, Shevchenko I, Umansky V, Nettelbeck DM, Weichert W, Jäger D, von Kalle C, Ungerechts G. Engeland CE, et al. Among authors: ungerechts g. Mol Ther. 2014 Nov;22(11):1949-59. doi: 10.1038/mt.2014.160. Epub 2014 Aug 26. Mol Ther. 2014. PMID: 25156126 Free PMC article.
Virotherapy Research in Germany: From Engineering to Translation.
Ungerechts G, Engeland CE, Buchholz CJ, Eberle J, Fechner H, Geletneky K, Holm PS, Kreppel F, Kühnel F, Lang KS, Leber MF, Marchini A, Moehler M, Mühlebach MD, Rommelaere J, Springfeld C, Lauer UM, Nettelbeck DM. Ungerechts G, et al. Hum Gene Ther. 2017 Oct;28(10):800-819. doi: 10.1089/hum.2017.138. Hum Gene Ther. 2017. PMID: 28870120 Review.
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.
Bourgeois-Daigneault MC, Roy DG, Aitken AS, El Sayes N, Martin NT, Varette O, Falls T, St-Germain LE, Pelin A, Lichty BD, Stojdl DF, Ungerechts G, Diallo JS, Bell JC. Bourgeois-Daigneault MC, et al. Among authors: ungerechts g. Sci Transl Med. 2018 Jan 3;10(422):eaao1641. doi: 10.1126/scitranslmed.aao1641. Sci Transl Med. 2018. PMID: 29298865
55 results